Response of isolated human neurogenic bladders to tachykinins.
Tachykinins act as stimulants of the isolated urinary bladder. However, the efferent role of tachykinins on detrusor function is controversial. We investigated the contractility of isolated human neurogenic bladders taken from patients with myelomeningocele or sacral agenesis, and tested the response to neurokinin A (NKA), neuromedin K (NKB), and substance P (SP). The contractile strengths were compared with normal controls. All tachykinins investigated induced significant contractions in both neurogenic and control bladders. The rank order of contractile potency was the same in both groups, namely, NKA > NKB > SP. The contraction induced by SP was not affected by atropine, but was completely blocked by [Sar9,Met(O2)11]-SP (a SP antagonist). Responses to electrical field stimulation were not changed by the SP antagonist. The contractile magnitude to field stimulation was also not altered by administration of 10(-6) M tachykinins. Responses of the neurogenic bladder to NKA and SP were significantly greater than the control. There were no differences in the response to KCl administration between the 2 groups. We conclude that hypersensitivity to NKA and SP in neurogenic bladders may contribute to bladder dysfunction in patients with sacral cord lesions.
Ohmura
M
M
Department of Urology, Nagoya University School of Medicine, Japan.
Kondo
A
A
Saito
M
M
D000293:Adolescent; D001285:Atropine / Q000494:pharmacology; D002648:Child; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008591:Meningomyelocele / Q000150:complications; D009119:Muscle Contraction / Q000187:drug effects*; D015288:Neurokinin A / Q000494:pharmacology; D015287:Neurokinin B / Q000494:pharmacology; D012445:Sacrococcygeal Region / Q000002:abnormalities; D013373:Substance P / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology; D015320:Tachykinins / Q000494:pharmacology*; D001750:Urinary Bladder, Neurogenic / Q000150:complications / Q000503:physiopathology* / Q000601:surgery
D015320:Tachykinins; C062618:substance P, Sar(9)-Met(O2)(11)-; D013373:Substance P; D001285:Atropine; D015288:Neurokinin A; D015287:Neurokinin B